Moat Ross sold KNSA
November 2, 2026 · Form 4 insider transaction
Moat Ross sold 722 shares of Kiniksa Pharmaceuticals International, plc at $94.05 per share, a transaction worth $67.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
722
Price
$94.05
Total value
$67.9K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 3, 2026
Shares owned after10,294
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging from $93.94 to $94.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.